129P Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort

Autor:	M. Kwa, Judith D. Goldberg, Tsivia Hochman, S. Zamora, Yelena Novik, Sylvia Adams, M Meyers, R. Oratz, N. Klar, J. Speyer, Franco M. Muggia
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry HER2 negative Phases of clinical research Hematology Pembrolizumab medicine.disease Metastatic breast cancer Hormone receptor Internal medicine Cohort medicine business Nab-paclitaxel
Zdroj:	Annals of Oncology. 31:S59
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9d8d72660a4f25e5090c2c5b46e2e633 https://doi.org/10.1016/j.annonc.2020.03.232 Zobrazit plný text záznamu